Alice Lione – Pagina 120 – AMD

Alice Lione

Novembre 15, 2022 Alice Lione

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months

Guerci B, Giorgino F, Sapin H, et al.
Diabetes Obes Metab. 2022;24(12):2373-2382.

Leggi

Novembre 15, 2022 Alice Lione

Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort

Dal Canto E, Elders PJM, van der Heijden AA, et al.
Diabetologia. Pub. online 8 Nov 2022.

Leggi

Novembre 15, 2022 Alice Lione

Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial

Succurro E ,Vizza P, Papa, et al.
Diabetes Obes Metab. 2022;24(12):2319-2330.

Leggi

Novembre 15, 2022 Alice Lione

Relationship between a novel non–insulin-based metabolic score for insulin resistance (METS‐IR) and coronary artery calcification

Zhenwei Wang, Xiaofang Hui, Huang X, et al.
BMC Endocr Disord. 2022;22(1):274.

Leggi

Novembre 15, 2022 Alice Lione

The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes

Thomas NJ, Walkey HC, Kaur A, et al.
Diabetologia. Pub. online 10 Nov 2022.

Leggi

Novembre 14, 2022 Alice Lione

SCIENTIFIC TALK AMD | 5 dicembre 2022 | ore 17

Leggi

Novembre 11, 2022 Alice Lione

GIORNATA MONDIALE DEL DIABETE 2022 – SEGUI LA CONFERENZA STAMPA IN DIRETTA

Leggi

Novembre 10, 2022 Alice Lione

Atrial fibrillation and dapagliflozin efficacy in patients with preserved or mildly reduced ejection fraction

Butt JH, Kondo T, Jhund PS, et al.
J Am Coll Cardiol. 2022;80(18):1705–1717.

Leggi

Novembre 15, 2022 Alice Lione

The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery

Khunti K, Aroda VR, Aschner P, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00278-9.

Leggi

Novembre 10, 2022 Alice Lione

An assessment of clinical continuous glucose monitoring targets for older and high-risk people living with type 1 diabetes

O’Neal DN, Cohen O, Vogrin S, et al.
Diabetes Technol Ther. Pub. online 31 Oct 2022

Leggi